SOX2 and breast neoplasm: Analyses of Hippo pathway markers in patient samples revealed that compared to their respective normal tissues, enhanced expressions of YAP/TAZ and the stemness markers, SOX2 and ALDH1A1, were observed in both naïve and chemotherapy-treated breast tumors.